British American Tobacco dividend income is the kind of idea that appeals to investors who want cash flow without taking on extra work. The maths behind a £6,622 annual second income is straightforward enough, but the sustainability of the yield deserves a closer look.
Building a £6,622 Second Income: The Maths
Three variables drive the outcome: how much you invest each month, for how long, and at what dividend yield.
Take £500 a month invested over 15 years, with dividends reinvested rather than taken as cash. Compounding at 5% annually, the portfolio would grow to just over £132,000. At a 5% dividend yield on that pot, the annual income would reach £6,622.
The same logic works at smaller or larger contribution levels; the income scales accordingly. A 5% yield is above the roughly 3% currently on offer from the FTSE 100 index, but it is not out of reach for investors willing to look further down the market.
British American Tobacco (LSE: BATS) is one candidate. The London Stock Exchange-listed company currently yields around 5.4%, above the 5% target in the model above.
BAT’s Dividend Track Record and the Risks
BAT has grown its dividend per share every year for decades. Its board declared an interim dividend of 245.04 pence per ordinary share for the year ended 31 December 2025, payable in four equal quarterly instalments of 61.26 pence, running from May 2026 through to February 2027, according to the BAT quarterly dividend payments page.
No dividend is guaranteed, and the structural pressure on cigarette volumes is real. Full-year 2025 cigarette volumes fell to 465 billion sticks from 505 billion sticks in 2024, according to BAT’s 2025 combined performance summary. Revenue followed: total Group revenue for 2025 came in at £25,610 million versus £25,867 million in 2024.
The offsetting factor is pricing power and a growing non-cigarette business. New Categories revenue rose to £3,621 million in 2025 from £3,432 million in 2024, with Modern Oral volume up 47% to 12.2 billion pouches over the same period.
The half-year picture for the six months ended 30 June 2025 tells a similar story. BAT reported revenue of £12,069 million, down 2.2% as reported but up 1.8% at constant foreign exchange rates, with smokeless products representing 18.2% of Group revenue, up 70 basis points versus the full-year 2024 figure, according to the BAT H1 2025 half-year report.
New Categories revenue in the first half was £1,651 million, in line with the same period in 2024 in reported terms but up 2.4% at constant exchange rates. BAT said it expected phased innovation roll-outs to drive an accelerated New Categories performance in the second half of 2025.
BAT’s full-year 2025 guidance, set out in its H1 interim results and confirmed in an SEC filing, included net finance costs of approximately £1.8 billion (adjusted for Canada), gross capital expenditure of approximately £650 million, and operating cash flow conversion exceeding 90%. The company also targets deleveraging to a 2.0 to 2.5 times adjusted net debt to adjusted EBITDA corridor by 2026, adjusted for Canada.
Those targets point to a business intent on generating cash, which underpins the dividend. The risk is that cigarette volume declines eventually outpace pricing gains and non-cigarette growth, squeezing the payout. That is a long-cycle risk rather than an immediate one, but investors in it for a 15-year compounding horizon need to keep it in view.
Getting Started With Dividend Investing
Diversification matters as much as yield selection. Concentrating a second-income strategy in a single stock, however generous the dividend, magnifies the impact of any cut.
The practical first step is establishing a wrapper: a Stocks and Shares ISA shelters dividend income from UK tax up to the annual subscription limit, and a share-dealing account offers flexibility beyond that.
From there, the approach is repetitive by design: regular monthly contributions, dividends reinvested, and a portfolio spread across several income-generating companies. The compounding does its work over time.
BAT’s next quarterly dividend instalment is due in August 2026. Whether the stock still yields 5%-plus at that point will depend in part on how the Modern Oral and vapour categories perform against the ongoing decline in combustible volumes through the rest of the year.
